Santhosh Palani - Mar 4, 2024 Form 3 Insider Report for Acrivon Therapeutics, Inc. (ACRV)

Role
Director
Signature
/s/ Rasmus Holm-Jorgensen, Attorney-in-Fact
Stock symbol
ACRV
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
3
Date filed
3/6/2024, 04:29 PM
Next filing
Mar 13, 2024

No securities are beneficially owned.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney